Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Welte

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Cancer Treatment and Research|November 6, 2010
Cyclic and chronic neutropeniaDavid C Dale, Karl Welte
Blood|September 21, 2006
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term surveyManuela Germeshausen, Matthias Ballmaier, Karl Welte
Reviews in Clinical and Experimental Hematology|December 25, 2003
Congenital neutropeniasCornelia Zeidler, Beate Schwinzer, Karl Welte
Current Opinion in Rheumatology|October 6, 2007
Severe congenital neutropenia: new genes explain an old diseaseGeorg Bohn, Karl Welte, Christoph Klein
Human Mutation|February 14, 2006
MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the diseaseManuela Germeshausen, Matthias Ballmaier, Karl Welte
Blood|November 21, 2008
In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropeniaManuela Germeshausen, Karl Welte, Matthias Ballmaier
Seminars in Hematology|July 11, 2006
Severe congenital neutropeniaKarl Welte, Cornelia Zeidler, David C Dale
Immunology and Allergy Clinics of North America|April 22, 2008
Congenital neutropenia syndromesKaan Boztug, Karl Welte, Cornelia Zeidler, et al.
BMC Blood Disorders|April 25, 2001
Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapyMartin Stanulla, André Schrauder, Karl Welte, et al.
British Journal of Haematology|January 6, 2009
Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropeniaCornelia Zeidler, Manuela Germeshausen, Christoph Klein, et al.
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Cancer Treatment and Research|November 6, 2010
Cyclic and chronic neutropeniaDavid C Dale, Karl Welte
Blood|September 21, 2006
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term surveyManuela Germeshausen, Matthias Ballmaier, Karl Welte
Reviews in Clinical and Experimental Hematology|December 25, 2003
Congenital neutropeniasCornelia Zeidler, Beate Schwinzer, Karl Welte
Current Opinion in Rheumatology|October 6, 2007
Severe congenital neutropenia: new genes explain an old diseaseGeorg Bohn, Karl Welte, Christoph Klein
Human Mutation|February 14, 2006
MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the diseaseManuela Germeshausen, Matthias Ballmaier, Karl Welte
Blood|November 21, 2008
In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropeniaManuela Germeshausen, Karl Welte, Matthias Ballmaier
Seminars in Hematology|July 11, 2006
Severe congenital neutropeniaKarl Welte, Cornelia Zeidler, David C Dale
Immunology and Allergy Clinics of North America|April 22, 2008
Congenital neutropenia syndromesKaan Boztug, Karl Welte, Cornelia Zeidler, et al.
BMC Blood Disorders|April 25, 2001
Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapyMartin Stanulla, André Schrauder, Karl Welte, et al.
British Journal of Haematology|January 6, 2009
Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropeniaCornelia Zeidler, Manuela Germeshausen, Christoph Klein, et al.
Pageof 15